Quipt Home Medical (QIPT)

Quipt Home Medical Stock Analysis & Ratings

QIPT Stock Chart & Stats

Day’s Range$4.56 - $4.68
52-Week Range$4.00 - $7.72
Previous Close$4.62
Average Volume (3M)58.85K
Market Cap$155.25M
P/E Ratio-14.0
Next EarningsAug 22, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
Smart Score5
EPS (TTM)-0.33



P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.



What was Quipt Home Medical’s price range in the past 12 months?
Quipt Home Medical lowest stock price was $4.00 and its highest was $7.72 in the past 12 months.
    What is Quipt Home Medical’s market cap?
    Quipt Home Medical’s market cap is $155.25M.
      What is Quipt Home Medical’s price target?
      The average price target for Quipt Home Medical is $9.90. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $11.00 ,the lowest forecast is $8.77. The average price target represents 113.82% Increase from the current price of $4.63.
        What do analysts say about Quipt Home Medical?
        Quipt Home Medical’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 3 Wall Streets Analysts.
          When is Quipt Home Medical’s upcoming earnings report date?
          Quipt Home Medical’s upcoming earnings report date is Aug 22, 2022 which is in 87 days.
            How were Quipt Home Medical’s earnings last quarter?
            Quipt Home Medical released its earnings results on May 16, 2022. The company reported $0.14 earnings per share for the quarter, beating the consensus estimate of $0.005 by $0.135.
              Is Quipt Home Medical overvalued?
              According to Wall Street analysts Quipt Home Medical’s price is currently Undervalued.
                Does Quipt Home Medical pay dividends?
                Quipt Home Medical does not currently pay dividends.
                What is Quipt Home Medical’s EPS estimate?
                Quipt Home Medical’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does Quipt Home Medical have?
                Quipt Home Medical has 33,560,000 shares outstanding.
                  What happened to Quipt Home Medical’s price movement after its last earnings report?
                  Quipt Home Medical reported an EPS of $0.14 in its last earnings report, beating expectations of $0.005. Following the earnings report the stock price went down -0.455%.
                    Which hedge fund is a major shareholder of Quipt Home Medical?
                    Currently, no hedge funds are holding shares in QIPT


                    Quipt Home Medical Stock Analysis

                    The Quipt Home Medical stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                    Learn more about TipRanks Smart Score

                    Company Description

                    Quipt Home Medical

                    Protech Home Medical Corp provides in-home monitoring equipment, supplies and services to patients. The company's services consist of Daily & Ambulatory Aides, Power Mobility, INR Self-Testing, Respiratory Equipment Rental, Home ventilation, Oxygen Therapy, and Sleep Apnea & PAP Treatment.

                    Similar Stocks
                    Price & Change
                    Viemed Healthcare
                    Xebec Adsorption
                    Antibe Therapeutics

                    Popular Stocks

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis